HCA Healthcare Inc. (HCA) 12-Month Stock Forecast & Price Target Cone
HCA Healthcare Inc. (HCA) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (41% profit margin, 19% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
Drag to Test Your HCA Position Size: $10,000
Wall Street Analyst Breakdown & Historical Accuracy Audit (34 Desks)
Street Historical Accuracy: 64/100| Wall Street Firm | Stance | 12M Target | 1Y Accuracy | Track Grade |
|---|---|---|---|---|
| Morgan StanleyInstitutional Equity Desk | OUTPERFORM | $526 | 74% | A |
| Goldman SachsSector Coverage Lead | BUY | $561 | 69% | B |
| JP MorganUS Large-Cap Research | HOLD | $449 | 58% | C |
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live HCA Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
HCA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +7.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HCA today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HCA. Explore sector supply chains on /butterfly.
HCA Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhat is HCA's 12-month stock price target?
HCA Healthcare Inc. (HCA) carries a 12-month consensus base price target of $506.05 (+5.9% from $478.08), with a bull-case target of $597.14 and a bear-case floor of $392.03.
Is HCA stock a Buy, Hold, or Sell right now?
Roarable's 5-Pillar RQD Quant Engine rates HCA B- (Buy — BUY) with an RQD Confidence score of 71/100.